Continuing a long-term commitment to improving outcomes for lung cancer patients by supporting the next generation of lung cancer researchers, LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit, has issued five Requests for Application (RFAs).
|
[25-January-2023] |
Applications are now available online WASHINGTON, Jan. 25, 2023 /PRNewswire/ -- Continuing a long-term commitment to improving outcomes for lung cancer patients by supporting the next generation of lung cancer researchers, LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit, has issued five Requests for Application (RFAs). “Lung cancer continues to be the number one cancer killer in the United States, but it is woefully underfunded. Only 6% of federal government dollars spent on cancer research go toward lung cancer research. LUNGevity is stepping up to help maintain a strong pipeline of lung cancer researchers,” said Upal Basu Roy, PhD, MPH, LUNGevity’s executive director of research. “Each of our Award Programs is strategically designed to overcome critical challenges facing the lung cancer community. For example, we have an award focused on improving early detection — a critical need in our community — as we build a world where no one dies of lung cancer.”
“Over the past decade, LUNGevity’s research portfolio has grown and evolved as we learned more about the biology of lung cancer and how to treat it,” said Charles Rudin, MD, PhD, chief of Memorial Sloan Kettering Cancer Center Thoracic Oncology Service and chair of LUNGevity’s Scientific Advisory Board. “LUNGevity’s longstanding focus on developing a strong lung cancer workforce is a powerful approach that is complemented by strategically targeting key, impactful investments in lung cancer research for both early detection and novel therapeutics. Taken together, they are likely to yield exciting results in lung cancer for many years to come.” All LUNGevity RFAs listed above have a two-step application process. An applicant must first submit a letter of intent (LOI) due February 27, 2023. Only a subset of applicants will be invited to submit a full application after the LOIs are reviewed; these applications will be due May 8, 2023. Award recipients are expected to be announced in late summer 2023. For more information about these awards, including full application details, visit the LUNGevity website at LUNGevity.org/apply-for-award and the proposalCENTRAL website at proposalcentral.com. About LUNGevity Foundation LUNGevity Foundation is the nation’s leading lung cancer organization focused on improving outcomes for people with lung cancer. The foundation works tirelessly to advance research into early detection and more effective treatments, and to ensure that patients have access to these advances. LUNGevity seeks to make an immediate impact on quality of life and survivorship for everyone touched by the disease—while promoting health equity by addressing disparities throughout the care continuum. LUNGevity provides information and educational tools to empower patients and their caregivers, promote impactful public policy initiatives, and amplify the patient voice through research and engagement. The organization provides an active community for patients and survivors—and those who help them live better and longer lives. Comprehensive resources include a medically vetted and patient-centric website, a toll-free HELPLine for support, the International Lung Cancer Survivorship Conference, and an easy-to-use Clinical Trial Finder, among other tools. All of these programs are to achieve our vision—a world where no one dies of lung cancer. LUNGevity Foundation is proud to be a four-star Charity Navigator organization. About Lung Cancer in the US
Please visit LUNGevity.org to learn more.
SOURCE LUNGevity Foundation |